Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice

Li, Tao; Li, Kenan; Zhang, Shan; Wang, Yafeng; Xu, Yiran; Cronin, Shane J. F.; Sun, Yanyan; Zhang, Yaodong; Xie, Cuicui; Rodriguez, Juan; Zhou, Kai; Hagberg, Henrik; Mallard, Carina; Wang, Xiaoyang; Penninger, Josef M.; Kroemer, Guido; Blomgren, Klas; Zhu, Changlian

doi:10.1038/s41419-020-2280-z

Download PDF

Article
Open access
Published: 30 January 2020

Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice

Tao Li^1,2,3,
Kenan Li^1,2,
Shan Zhang^1,2,
Yafeng Wang^1,2,3,
Yiran Xu^1,2,
Shane J. F. Cronin⁴,
Yanyan Sun^1,2,
Yaodong Zhang^2,3,
Cuicui Xie^2,5,
Juan Rodriguez²,
Kai Zhou^2,5,
Henrik Hagberg⁶,
Carina Mallard^6,7,
Xiaoyang Wang^1,6,7,
Josef M. Penninger^4,8,
Guido Kroemer^{9,10,11,12,13},
Klas Blomgren^5,14 &
…
Changlian Zhu ORCID: orcid.org/0000-0002-5029-6730^1,2,5,6

Cell Death & Disease volume 11, Article number: 77 (2020) Cite this article

3230 Accesses
28 Citations
1 Altmetric
Metrics details

Subjects

Abstract

Apoptosis inducing factor (AIF) has been shown to be a major contributor to neuron loss in the immature brain after hypoxia-ischemia (HI). Indeed, mice bearing a hypomorphic mutation causing reduced AIF expression are protected against neonatal HI. To further investigate the possible molecular mechanisms of this neuroprotection, we generated an AIF knock-in mouse by introduction of a latent transgene coding for flagged AIF protein into the Rosa26 locus, followed by its conditional activation by a ubiquitously expressed Cre recombinase. Such AIF transgenic mice overexpress the pro-apoptotic splice variant of AIF (AIF1) at both the mRNA (5.9 times higher) and protein level (2.4 times higher), but not the brain-specific AIF splice-isoform (AIF2). Excessive AIF did not have any apparent effects on the phenotype or physiological functions of the mice. However, brain injury (both gray and white matter) after neonatal HI was exacerbated in mice overexpressing AIF, coupled to enhanced translocation of mitochondrial AIF to the nucleus as well as enhanced caspase-3 activation in some brain regions, as indicated by immunohistochemistry. Altogether, these findings corroborate earlier studies demonstrating that AIF plays a causal role in neonatal HI brain injury.

Pyk2 inhibition attenuates hypoxic-ischemic brain injury in neonatal mice

Article 05 July 2021

PHLDA1 contributes to hypoxic ischemic brain injury in neonatal rats via inhibiting FUNDC1-mediated mitophagy

Article 15 May 2024

KLF2 up-regulates IRF4/HDAC7 to protect neonatal rats from hypoxic-ischemic brain damage

Article Open access 28 January 2022

Introduction

Hypoxic-ischemic encephalopathy (HIE) is a severe central nervous system injury that manifests in neonates as a consequence of perinatal asphyxia. HIE is an important cause of neonatal mortality and of serious and devastating lifelong disabilities such as cerebral palsy, neurosensory deficits, and cognitive impairments in both term and preterm neonates¹. The incidence of HIE ranges from 1 to 8 per 1000 live births in developed countries and is as high as 26 per 1000 live births in underdeveloped countries¹. HIE accounts for up to 22% of all neonatal deaths worldwide². Therapeutic hypothermia has been widely implemented and modestly improves outcome in full-term infants^3,4. Erythropoietin treatment also demonstrates remarkable neuroprotection in both term and preterm infants^5,6,7. However, hypothermia therapy is limited to full-term infants, and the window of opportunity for erythropoietin treatment is still unclear. Thus, a better understanding of the mechanisms of neuronal cell death and brain injury after HI is warranted in order to develop novel strategies for the prevention and treatment of neonatal brain injury.

The neonatal brain is particularly vulnerable to oxidative damage because of an elevated rate of oxygen consumption, low concentrations of antioxidants, and the availability of redox-active iron⁸. Therefore, oxidative stress, excitotoxicity, inflammatory responses, and activation of several distinct cell death pathways, including apoptosis, necrosis, necroptosis, ferroptosis, and autophagy, commonly occur in the neonatal brain after HI^9,10,11,12. Because apoptosis is critical for normal brain development and determines the size and shape of the central nervous system¹⁰, the neonatal brain is likely more susceptible to this cell death pathway than the adult brain¹³. Thus, apoptosis is thought to account for a significant portion of the neuronal cell loss associated with neonatal HI¹⁴.

AIF is a flavoprotein located in the mitochondrial intermembrane space and has a dual role in controlling cell survival and death^15,16. Since its discovery, the role of AIF in the apoptotic process has been studied extensively^17,18. In response to pro-apoptotic signals, AIF translocates from the mitochondria to the nucleus where it interacts with DNA and stimulates chromatin condensation as well as high molecular weight DNA fragmentation¹⁹. AIF is synthesized in the cytosol and subsequently imported into the mitochondrial intermembrane space where it is required for maintaining mitochondrial morphology and cristae structure²⁰. Mitochondrial morphology is dynamically controlled by a balance between organelle fission and fusion²¹, and this dynamic equilibrium can be disrupted by AIF deficiency²². Studies show that mitochondrial dynamics can be disrupted by HI injury in the immature brain and by ischemia/reperfusion in the adult brain^{18,23,24,25,26,27}. Thus, mitochondrial dynamics might be related to the pathophysiological processes of HI-induced brain injury. Our previous studies have shown that AIF is a major contributor to neuronal loss induced by neonatal cerebral HI^17,28. Harlequin mice, which bear a hypomorphic mutation in the Aif gene causing ~80% reduction in AIF protein level, experience significant neuroprotection in ischemic brain injury models^17,29. However, it has been debated whether it is the reduction of AIF translocation to the nucleus or the downregulation of mitochondrial respiratory activity that accounts for reduced neuronal cell death in Harlequin mice^14,17,29. Indeed, AIF deficiency entails a defect in oxidative phosphorylation that, on theoretical grounds, could reduce the production of deleterious reactive oxygen species (ROS) in the context of HI³⁰. To further confirm the effect of AIF on neuronal cell death, we generated an AIF knock-in mouse by introduction of a latent transgene (inactivated by a Lox-Stop-Lox cassette) coding for flagged AIF protein into the Rosa26 locus, followed by its conditional activation by Cre recombinase expressed under the control of the ubiquitous Actin promoter. By using AIF-overexpressing transgenic mice, we investigated the effect of AIF on neonatal brain injury after HI and potential molecular mechanisms. We found that AIF overexpression aggravated neonatal brain injury after HI.

Results

AIF-overexpressing mice have a normal phenotype

Two isoforms of AIF have been identified according to whether exon 2a or 2b of the Aif gene is expressed. AIF1 (which uses exon 2a) was the first to be described and is the most abundant and ubiquitous isoform, while AIF2 (which uses exon 2b) is restricted to the central nervous system and thus is called the brain-specific isoform³¹. AIF2 is more strongly anchored to the inner mitochondrial membrane than AIF1, and we previously showed that a lack of AIF2 aggravated cerebral damage in a model of neonatal HI³². In contrast, reduction of AIF1 expression reduces neuronal cell loss under identical conditions¹⁷. Driven by these considerations, we first investigated which AIF isoform would be overexpressed in transgenic mice. The relative abundance of Aif1 and Aif2 mRNA transcripts in the brains of WT and AIF Tg mice at postnatal day (P) 9 was determined by quantitative reverse transcription PCR (RT-qPCR). Under physiological conditions, Aif1 mRNA expression in AIF Tg mice was 5.9 times higher than in the WT mice at P9 (Fig. 1b). In contrast, there was no significant difference in Aif2 mRNA expression between WT and AIF Tg mice (Fig. 1c). Compared with WT controls, two AIF protein bands were detected in the AIF Tg mice, the upper band was the transgenic AIF with a FLAG tag (FLAG-AIF), which has a higher molecular weight and so can be distinguished from endogenous AIF, which was represented by the lower band. (Fig. 1d). The abundance of total AIF protein was 2.4 times greater in AIF Tg than in WT mice at P9 (Fig. 1e). Other mitochondria-related proteins, including coiled-coil-helix-coiled-coil-helix domain-containing protein 4 (CHCHD4), cytochrome C oxidase subunit I (COX1), cytochrome C (CYTC), a peripheral protein of the mitochondrial inner membrane (which functions as an essential electron shuttle between complex III and complex IV of the respiratory chain, but also plays a prominent role in post-mitochondrial caspase activation), superoxide dismutase 2 (SOD2), voltage dependent anion channel 1 (VDAC1), and mitochondrial biogenesis-related proteins, including peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) and transcription factor A, mitochondrial (TFAM), showed no difference between WT and AIF Tg mice at P9 (Fig. 1d, f). To further evaluate oxidative phosphorylation in the brain of AIF Tg mice, the activity of mitochondrial oxidative phosphorylation (OXPHOS) complex I was measured. This activity exhibited a trend towards a non-significant increase in AIF Tg mice (Fig. 1g). AIF Tg mice normally survived well beyond 1 year of age without showing any major phenotypic or behavioral alterations. No significant difference in body weight was detected in P9 or 12-month-old WT and AIF Tg mice (Fig. 1h, i). The neuronal proliferation marker doublecortin (DCX), which is a microtubule-associated protein expressed by neuronal precursor cells, was determined in 1-year-old mice. The density of DCX-positive cells in the granular layer of the dentate gyrus was higher in AIF Tg mice than in WT mice (p = 0.006) (Fig. 1j, k).

**Fig. 1: Expression of mitochondria-related proteins in P9 AIF Tg mice under physiological conditions.**

To further investigate whether AIF overexpression has an impact on the mRNA transcriptome under physiological conditions, the transcriptomes of six P9 male mouse brain tissues from the cortex were determined by RNA sequencing. Even when using the relaxed criterion of p < 0.05, the data analysis showed that only 369 of the total of 21,762 genes were differentially expressed in AIF Tg mice compared to WT mice (Fig. 2a). Among these 369 genes, 183 were upregulated and 186 were downregulated. Gene ontology (GO) term classification was performed on the differentially expressed genes (DEGs) in three ontologies (molecular biological function, cellular component, and biological process), but no specific terms were found among the top ten classified GO terms (Fig. 2b).

**Fig. 2: AIF overexpression had no significant impact on the transcriptome in the cortex of P9 mice.**

AIF overexpression aggravates brain injury in neonatal HI mice

HI-induced brain injury in neonatal mice was evaluated via immunohistochemistry staining for markers of gray matter (MAP2, microtubule associated protein 2) and white matter (MBP, myelin basic protein) in brain tissues at 72 h after HI. The injury encompassed the cortex, hippocampus, striatum, and thalamus, as indicated by MAP2 staining of brain coronal sections, and AIF overexpression significantly increased the severity of brain injury after HI (Fig. 3a). The extent of gray-matter injury, as indicated by the infarction volume, increased by 74.6%, from 7.32 ± 6.25 mm³ in WT mice to 12.78 ± 8.89 mm³ in AIF Tg mice (p = 0.0154) (Fig. 3b). No significant difference was found between male and female AIF Tg mice (13.62 ± 9.30 mm³ vs. 11.71 ± 8.66 mm³, respectively, p = 0.7907). The total neuropathological score was significantly higher for AIF Tg mice compared to WT controls (p < 0.001) (Fig. 3c). AIF overexpression increased HI-induced brain injury in all observed brain regions, in particular in the cortex, hippocampus, and striatum (Fig. 3d). Myelination was visualized in the subcortical white matter by MBP staining at 72 h after HI (Fig. 3e), and the total lost volume of subcortical white matter in the ipsilateral hemisphere was greater in the AIF Tg mice as compared to WT mice at 72 h after HI (p = 0.0107) (Fig. 3f). However, no difference was found between male and female in AIF Tg mice.

**Fig. 3: AIF overexpression increased brain injury after HI.**

AIF overexpression affects apoptotic cell death pathways

The enhanced propensity of immature brain cells to undergo apoptosis compared to the adult brain involves both caspase-dependent and caspase-independent pathways. Thus, combined inhibition of both pathways provides synergistic protection against neonatal HI brain injury¹⁷. AIF is one of the major components of the caspase-independent apoptotic cell death pathway, and AIF nuclear translocation was significantly increased in several brain regions at 24 h post-HI (Fig. 4a). AIF staining showed that the number of AIF-positive nuclei in the AIF Tg mice was 3 times greater in the cortex (p < 0.001), 1.8 times higher in the cornu ammonis area 1 (CA1) (p = 0.0368), 1.3 times higher in the striatum (p = 0.0299), and 3.1 times higher in the habenular nuclei (p < 0.001) than in WT mice (Fig. 4b–e). To clarify the nuclear translocation of exogenous AIF, immunostaining with a FLAG antibody, which can recognize the transgene-encoded AIF protein (which was tagged with a FLAG^® peptide sequence), was performed (Fig. 4f). Immunofluorescence staining using AIF (green)/FLAG (red) antibodies confirmed that exogenous AIF contributes to HI-induced nuclear translocation and apoptotic cell death (Fig. 4g).

**Fig. 4: AIF overexpression increased AIF nuclear translocation in the brain after HI.**

Caspase-dependent apoptotic cell death was investigated by immunostaining of active caspase-3 in different brain regions at 24 h after HI, which is when caspase-3 activation reaches its peak¹³ (Fig. 5a). In the observed brain regions, caspase-3-positive cells were significantly increased in the cortex and striatum from AIF Tg mice as compared to WT mice, but no significant changes were seen in CA1 or the habenular nuclei (Fig. 5b–e). Quantification of active caspase-3-positive cells showed 1.6 times more cells in the cortex (p = 0.0481) and 1.2 times more cells in the striatum (p = 0.0012) from AIF Tg mice than in WT mice (Fig. 5c, e). Caspase-3 activity in the ipsilateral cortex was significantly increased, but no significant difference was found between WT and AIF Tg mice (Fig. 5f). Poly (ADP-ribose) polymerase-1 (PARP-1) was semi-quantified by immunoblotting at 24 h after HI. Compared with the contralateral (CL) hemisphere, cleaved PARP-1 was significantly increased in the ipsilateral (IL) hemisphere (p < 0.001), but no significant difference was found in the IL hemisphere between WT and AIF Tg mice (p = 0.7299) (Fig. 5g, h).

**Fig. 5: AIF overexpression increased active caspase-3–positive cells in parts of the mouse brain after HI.**

AIF overexpression has no significant effects on mitochondria-related proteins after HI

To investigate the impact of AIF overexpression on mitochondrial cell death-related proteins after HI, the protein expression of total AIF, FLAG-AIF, CHCHD4, COX1, SOD2, and CYTC in the mitochondrial fraction of the cortical tissue was determined by immunoblotting at 24 h after HI (Fig. 6a). Comparing the CL hemisphere with the IL hemisphere, AIF protein was reduced in the IL hemisphere in both WT and AIF Tg mice, and this reduction was more pronounced in AIF Tg mice (p = 0.0284) (Fig. 6b), which indicates that more AIF was released from mitochondria after HI in the AIF Tg mice. Approximately 18% transgene-encoded (FLAG-positive) AIF was released from mitochondria at 24 h after HI (p = 0.019) (Fig. 6c). Because there are no specific antibodies to identify the two AIF isoforms, we used RT-qPCR to measure the mRNA expression of Aif1 and Aif2 at 24 h after HI. Aif1 mRNA expression was significantly upregulated in both WT and AIF Tg mice at 24 h after HI compared to their controls (p < 0.001 for WT mice and p = 0.0160 for AIF Tg mice). In sharp contrast, Aif2 was significantly downregulated in both WT and AIF Tg mice (p = 0.0031 for WT mice and p = 0.0352 for AIF Tg mice) (Fig. 6d). Quantification of mitochondria-related proteins CHCHD4 (p = 0.5403), COX1 (p = 0.1819), SOD2 (p = 0.1902), and CYTC (p = 0.6159) did not reveal any significant differences between WT and AIF Tg mice at 24 h after HI. However, CHCHD4 expression was increased in the IL hemisphere after HI in both WT and AIF Tg mice (Fig. 6e). Cyclophilin A (CYPA), an immunophilin, has a variety of intracellular functions, including signaling, protein trafficking, and the regulation of other proteins. CYPA participates in the nuclear translocation of AIF in neurons after cerebral hypoxia-ischemia³³. The CYPA concentration in the nuclear fraction was increased significantly in the IL hemispheres of both WT and AIF Tg mice (both p < 0.001), and the concentration of CYPA in the nuclear fraction of AIF Tg mice was significantly higher than that of WT mice (p = 0.0488) (Fig. 6f).

**Fig. 6: Changes in mitochondria-related proteins in the cortex after HI.**

AIF overexpression has no effects on mitochondrial dynamics

Mitochondrial morphology is determined by a dynamic equilibrium between organelle fusion and fission, and HI injury affects mitochondrial dynamics in the neonatal mouse brain²⁷. To investigate the effect of AIF overexpression on mitochondrial dynamics, the expression of the fission and fusion-related proteins phospho-dynamin-related protein 1 (P-DRP1), mitochondrial fission 1 (FIS1), OPA1 mitochondrial dynamin like GTPase (OPA1), and mitofusin 1 (MFN1) were determined in both P9 WT and AIF Tg mice under physiological conditions. No significant changes were found between the two genotypes (p = 0.3854 for P-DRP1, p = 0.6708 for FIS1, p = 0.1313 for the long form of OPA1, p = 0.4922 for the short form of OPA1, and p = 0.9470 for MFN1) (Fig. 7a, b). The expression of the fission proteins P-DRP1 and FIS1 were further determined at 24 h after HI (Fig. 7c). The abundance of P-DRP1 was reduced in the IL hemisphere in both WT and AIF Tg mice, but this difference was not significant. The long form of OPA1 was reduced in both WT and AIF Tg mice at 24 h after HI, and it was much less abundant in AIF Tg mice. In contrast, the short form and the cleavage band of OPA1 were significantly increased at 24 h after HI in the two genotypes (p = 0.0003 for WT and p = 0.0206 for AIF Tg). Comparing the CL and IL hemispheres, MFN1 expression was also significantly decreased in both WT and AIF Tg mice at 24 h after HI (p = 0.0029 for WT and p = 0.0025 for AIF Tg). The increased short form and cleavage product of OPA1 along with the reduction of MFN1 indicate that mitochondrial fusion was compromised after HI injury. However, there was no difference between WT and AIF Tg mice with respect to the cleavage of OPA1 and the depletion of MFN1 (Fig. 7d).

**Fig. 7: Effect of AIF overexpression on mitochondrial fission and fusion in the cortex.**

Discussion

AIF is a mitochondrial oxidoreductase that, if present in mitochondria, functions as an anti-apoptotic oxidoreductase³⁴. AIF also regulates the assembly and maintenance of the respiratory complexes, thus influencing metabolic pathways and epigenetic processes³⁵. Deficiency in AIF leads to severe mitochondrial dysfunction, causing muscle atrophy and neurodegeneration in model organisms as well as in humans^36,37,38. The Harlequin mouse with a mutation derived from a proviral insertion in the X-linked Aifm1 locus has an 80% reduction in Aifm1 mRNA expression. As a consequence of AIF deficiency, neurons from adult Harlequin mice suffer from greater oxidative stress, enhanced cell cycle re-entry, and progressive cerebellar degeneration³⁹. During apoptosis, AIF translocates from the mitochondria to the nucleus to act as a pro-apoptotic factor^40,41. The pro-apoptotic activity of AIF appears to dominate over its neuroprotective function in neonatal mice, meaning that Harlequin mice manifest reduced neuronal cell loss in response to HI compared to normal WT controls¹⁷.

However, the effect of AIF overexpression has not yet been reported in vivo. The AIF Tg mice reported here exhibited 5.9 times higher Aif1 mRNA expression (but no significant changes in Aif2 mRNA). In spite of the Aif1 hyperexpression, we observed no change in the expression of mitochondrial cell death-related proteins or mitochondrial biogenesis-related proteins under physiological conditions. Comparing body weight gain and mortality with WT mice, no specific phenotypes were observed in the P9 AIF Tg mice, but the increasing numbers of DCX-positive cells in the granular layer of the dentate gyrus in 1-year-old AIF Tg mice indicated that excessive AIF might increase neuronal proliferation in the long term but not affect the early stages of brain development. The transcriptome analysis showed fewer than 2% DEGs in the P9 mouse brain, even when using a relatively loose criterion for the definition of DEGs. All of these results suggest that excessive AIF does not have any major impact on physiological functions.

Apoptosis is critical for central nervous system development in the immature brain, and many of the proteins involved in apoptosis are upregulated during brain development¹⁰. Our previous studies showed that AIF translocates to the nucleus in the neonatal brain after HI²⁸ and that downregulation of AIF expression makes mice less vulnerable to HI injury¹⁷. Furthermore, blocking AIF translocation or downregulating AIF partner proteins reduces neuronal cell death and brain injury^15,18,33,42, suggesting that AIF plays a causal role in cell death. In the AIF Tg mice, the AIF protein was more than two-fold increased and AIF nuclear translocation was much more pronounced and resulted in more severe brain injury after HI as compared to WT mice with normal AIF protein expression. More CYPA was found in the nucleus of AIF Tg mice indicating that this cytosolic protein participates in the nuclear translocation of excessive AIF. These results are in accordance with our previous findings in which reduced AIF or blocking AIF translocation leads to reduced injury, which indicates that AIF protein expression is positively correlated with brain injury after HI¹⁷. In contrast, selective knockout of exon 2 (which abolishes expression of AIF2 but not AIF1) aggravates cerebral injury after HI injury³², indicating that AIF1 and AIF2 differ in their role in the neonatal brain after HI.

Caspases have proteolytic activity and are able to cleave proteins at aspartic acid residues. Caspase-3 is the most important executioner caspase. In the AIF Tg neonatal mouse brain, a significant increase in active-caspase3-positive cells was only found in the cortex and striatum regions at 24 h after HI, but not in the CA1 or the habenular nuclei, which are different in the composition of neuronal subpopulations⁴³. The hippocampus plays a role in memory consolidation and spatial navigation. The cell types are different between the hippocampus and the other brain regions, and the neuron densities in the main part of the hippocampus are lower than in the cortex⁴⁴. The differences in populations and types might cause cells to undergo different cell death pathways in different brain regions⁴⁵. Our present results indicate that the caspase3-independent cell death pathway is more pronounced than the caspase3-dependent pathway in the hippocampus.

AIF is critical for PARP-1-dependent cell death (parthanatos)^46,47,48. Excessive activation of PARP-1 leads to the formation of poly(ADP-ribose) polymer that translocates from the nucleus to the mitochondria resulting in the release of AIF and accompanying over consumption of NAD+ that results in a decrease in ATP production⁴⁹. PARP-1 is one of the caspase substrates, and cleavage of PARP-1 by caspases is considered to be a hallmark of apoptosis⁵⁰. In this study, HI insult induced caspase-3 activation and PARP-1 cleavage at 24 h, but no significant differences were found between the WT and Tg group. As we know, different cell death pathways might be activated by common upstream initiators and might even share intersecting signal transduction cascades in a complex crosstalk. However, the specific modalities of such a crosstalk and the preference for one or the other (caspase-dependent, caspase-independent) pathway might differ in distinct brain regions, or even in a sex-biased fashion, depending on the pathological conditions^51,52,53. This suggests that multipronged targeting of several cell death effectors is likely to be more effective in inhibiting cell death than acting on a single molecule only.

In living cells, mitochondria are continuously remodeled by fission and fusion events. These antagonistic processes link mitochondrial dynamics with the balance between energy demand and nutrient supply⁵⁴. Highly fused mitochondria are efficiently formed under nutrient deprivation or upon exposure to certain forms of stress in order to optimize mitochondrial function and hence to maximize ATP synthesis. In contrast, mitochondrial fission is frequently observed in excess nutrient environments, such as in obesity. These dynamic changes mean that maintaining or promoting mitochondrial fusion or inhibiting mitochondrial fission might have a protective effect against HI-induced injury. AIF deficiency reportedly can disrupt mitochondrial dynamics²². However, in the current study, AIF overexpression did not have any influence on the expression of mitochondrial fusion or fission-related proteins under physiological conditions. HI injury might reduce mitochondrial fusion, as indicated by decreased expression of the fusion proteins MFN1 and the long form of OPA1, and might increase mitochondrial fission, as indicated by downregulation of P-DRP1. Indeed, published results suggest that HI reduces mitochondrial fusion and increases mitochondrial fission to aggravate neonatal brain injury^23,24,55,56. However, no significant differences in proteins regulating mitochondrial fusion or fission were found between the WT and AIF Tg mice after HI, suggesting that the aggravation of HI injury in the neonatal brain due to excessive AIF expression is unlikely to be related to changes in mitochondrial dynamics.

There are some limitations in the current study. First, due to the fact that the mouse genotypes are complicated, we are restricted in the number of mice obtained from each of the genotypes, which prevented us from obtaining samples from more time points, such as 6 or 12 h post-HI. Second, even though some long-term study data in the non-injured mice have been included, we do not have long-term neurobehavioral function data after the HI injury. We found that AIF over expression aggravated brain injury after HI, but this would be more convincing if a long-term behavioral analysis could be performed.

In summary, our study demonstrates that excessive AIF does not initiate obvious phenotypic changes or changes to any physiological functions. Excessive AIF protein expression does, however, aggravate HI-induced injury mainly in the neonatal brain, correlating with a more prominent translocation of AIF release from the mitochondria to the nucleus of brain cells, as well as a brain region-specific increase in caspase-3 activation. Altogether, this study indicates a major role for AIF in neonatal HI brain injury. Future research should focus on strategies to prevent AIF release from the mitochondria and subsequent nuclear translocation after HI insult.

Materials and methods

Animals

The AIF overexpression transgenic mouse (AIF-Tg^flox/flox) was constructed in a C57/Bl6 background using Rosa26 locus gene targeting, and AIF overexpression was regulated by Cre recombinase. The floxed mice were crossed with beta-actin-cre mice. The AIF-Tg^flox/+-actin-cre (AIF overexpression, AIF Tg) and AIF-Tg^+/+-actin-cre (wild type, WT) mice with reasonable body weight (4.0–5.5 g) at P9 and each litter with 5–8 pups were used in this study. A total of 15 pups were excluded because of death during surgery or during hypoxia, and a total of 114 mouse pups were used for analysis. No statistical methods were engaged to predetermine sample size, and instead we based our experimental design on numbers reported in previous studies^11,18. All pups were grouped by genotypes, which means AIF Tg mice belong to experimental group and WT mice belong to control group. All the experimental protocol approved. All experimental procedures conformed to guidelines established by the Swedish Board of Agriculture (SJVFS 2019: 10), were approved by the Gothenburg Animal Ethics Committee (112/2014). The animal experiments were performed in the Laboratory for Experimental Biomedicine of Gothenburg University, and are reported in compliance with the ARRIVE (Animal Research: Reporting in vivo Experiments) guidelines. The sample collection time is indicated in Fig. 1a. Genomic DNA was isolated from tail samples (Qiagen, Hilden, Germany; 69506), and PCR was performed on a Biometra T3 Thermocycler (Biometra GmbH, Göttingen, Germany). The primers for the AIF transgenic flox gene were 5′-GAGTTCTCTGCTGCCTCCTG-3′ (forward), 5′-AAGACCGCGAAGAGTTTGTC-3′ (reverse for flox band, 215 bp), and 5′-CGAGGCGGATACAAGCAATA-3′ (reverse for wild type band, 322 bp), and the primer pair for the beta-actin-cre gene was 5′-CTGCCACGACCAAGTGACAGCAATG-3′ (forward) and 5′-GCCTTCTCTACACCTGCGGTGCTAA-3′ (reverse) to produce an amplicon of 326 bp. A 1.5% agarose gel electrophoresis system (Bio-Rad, California, US) and LAS 3000 cooled CCD camera (Fujifilm, Tokyo, Japan) were used for genotype detection.

Cerebral HI

Postnatal day (P)9 mice of both sexes were anesthetized with isoflurane (5% for induction, 1.5–2.0% for maintenance) in a 1:1 mixture of air and oxygen, and the duration of anesthesia and surgery was <5 min. The right common carotid artery was cut between double ligatures. After the surgical procedure, the wounds were infiltrated with xylocaine. Pups were returned to their dams for 1 h and then placed in a chamber perfused with a humidified gas mixture (10% ± 0.01% oxygen in nitrogen) for 40 min at 36 °C. After the hypoxic exposure, the pups were returned to their dams until sacrifice. Control pups were subjected to all procedures except HI.

Sample preparation for immunohistochemistry

Animals were deeply anesthetized with an overdose of sodium pentobarbital and perfused intracardially with PBS and 5% buffered formaldehyde (Histofix; Histolab, Gothenburg, Sweden). The brains were fixed in 5% buffered formaldehyde at 4 °C overnight. After dehydration with graded ethanol, the brains were embedded in paraffin and cut into 5-µm thick coronal sections, which were deparaffinized in xylene and rehydrated in graded ethanol. Antigen retrieval was performed by heating the sections in 10 mM boiling sodium citrate buffer (pH 6.0) for 10 min. The primary antibodies were as follows and were incubated with the sections overnight at 4 °C: mouse anti-MAP2 (1:1000 dilution, clone HM-2, Sigma, M4403), mouse anti-MBP (1:500 dilution, clone SMI94, BioLegend, 836504), rabbit cleaved caspase-3 (1:200 dilution, Asp175, Cell Signaling, 9661), rabbit anti-AIF (1:500 dilution, E20, Abcam, ab32516), and goat anti-DCX (1:500 dilution, C-18, Santa Cruz, sc-8066). After washing, the appropriate biotinylated secondary antibodies (1:200 dilutions; all from Vector Laboratories, Burlingame, CA, USA) were added to each section for 60 min at room temperature. The sections were visualized with a Vectastain Elite ABC Horseradish Peroxidase (HRP) Kit (Vector Laboratories, PK-6100).

For the immunofluorescence staining, the mixed primary antibodies of rabbit anti-AIF (1:500 dilution, E20, Abcam, ab32516) and mouse ANTI-FLAG (1:500 dilution, M2, Sigma, F1804) were incubated with the sections overnight at 4 °C. After washing, the mixed secondary antibodies of donkey anti-rabbit Alexa Fluor488 (1:500 dilution, Life Technology, A21206) and donkey anti-mouse Alexa Fluor555 (1:500 dilution, Life Technology, A31570) were added to each section for 120 min at room temperature. After washing, the sections were mounted on coverslips with ProLong^TM Gold anti-fade reagent with DAPI (Invitrogen, P36931).

Brain injury evaluation

Brain injury was evaluated based on MAP2 and MBP immunostainings. Both hemispheres of each section were measured using Micro Image (Olympus, Japan). MAP2-positive and negative and MBP-positive tissue volume calculations as well as neuropathological scores of the gray matter from different brain regions were assessed as described previously¹¹. The infarction volume was equal to the MAP2-negative volume in the IL hemisphere. MBP tissue loss ratio was calculated as: ((CL hemisphere − IL hemisphere)/CL hemisphere) × 100%. All evaluations were carried out by investigators blinded to group assignment.

Cell counting

Area contours with fixed location were drawn and measured in every 50th section. The active caspase-3-positive cells and AIF-positive nuclei were counted within a defined area (one visual field) of the cortex (100×), striatum (200×), CA1 (200×), and habenular nuclei (200×). The DCX-positive cells in the granular layer of the dentate gyrus in 1-year-old mice were counted at 100× magnification. Three sections were counted from each brain with an interval of 250 μm. All of the counting was carried out by investigators blinded to group assignment.

Sample preparation for immunoblotting and ELISA assay

The pups were sacrificed by decapitation at 24 h after HI. Tissue from the parietal cortex (including the hippocampus) in both hemispheres was rapidly dissected out and homogenized immediately on ice using a 2 ml Dounce tissue grinder set (Sigma, D8938), and isolation buffer was added (15 mM Tris-HCl, pH 7.6, 320 mM sucrose, 1 mM dithiothreitol, 1 mM MgCl₂, 3 mM EDTA-K, and 0.5% protease inhibitor cocktail (Sigma, P8340)). Half of the homogenate was aliquoted and stored at −80 °C, and the other half was centrifuged at 800 × g for 10 min at 4 °C. The pellet fraction was washed with the isolation buffer, re-centrifuged with the same procedure, and saved as the nuclear fraction. The supernatant was further centrifuged at 9200 × g for 15 min at 4 °C, producing enriched mitochondrial fractions in the pellet and crude cytosolic fractions in the supernatant. The pellet was washed and centrifuged again and then resuspended with isolation buffer. All fractions were kept at −80 °C.

Immunoblotting

Protein concentration was determined using the bicinchoninic acid method. Samples (65 µl) were mixed with 25 µl NuPAGE LDS 4× sample buffer (ThermoFisher Scientific, NP0007) and 10 µl reducing agent (ThermoFisher Scientific, NP0004) and heated at 70 °C for 10 min. Samples were run on 4–12% NuPAGE Bis-Tris gels (Invitrogen) and transferred to reinforced nitrocellulose membranes (Bio-Rad). After blocking with 5% fat-free milk in TBST buffer (20 mM Tris, 150 mM NaCl, and 0.1% Tween 20, pH 7.6) for 60 min at room temperature, the membranes were incubated with the following primary antibodies: rabbit anti-AIF (1:1000 dilution, E20, Abcam, ab32516), mouse ANTI-FLAG (1:1000 dilution, M2, Sigma, F1804), mouse anti-CHCHD4 (1:200 dilution, C-12, Santa Cruz, sc-365137), rabbit anti-COX1 (1:1000 dilution, EPR19628, Abcam, ab203912), rabbit anti-PGC1α (1:1000 dilution, ThermoFisher, PA5-38021), rabbit anti-TFAM (1:1000 dilution, ABclonal, A13552), rabbit anti-SOD2 (1:1000 dilution, ABclonal, A1340), mouse anti-cytochrome c (1:500 dilution, 6H2, Santa Cruz, sc-13561), rabbit anti-phospho-DRP1 (1:1000 dilution, Ser637, Cell Signaling, 4867), mouse anti-OPA1 (1:1000 dilution, BD bioscience, 612606), mouse anti-MFN1 (1:500 dilution, 11E9-1H12, Novus Biologicals, NBP1-71775), rabbit anti-FIS1 (1:500 dilution, FL-152, Santa Cruz, sc-98900), rabbit anti-PARP-1 (1:1000 dilution, E102, Abcam, ab32138), rabbit anti-cleaved PARP-1 (1:1000 dilution, E51, Abcam, ab32064), goat anti-Lamin B (1:200 dilution, M-20, Santa Cruz, sc-6217), and mouse anti-VDAC1 (1:500 dilution, B-6, Santa Cruz, sc-390996) overnight. After washing, the membranes were incubated with peroxidase-labeled goat anti-rabbit IgG antibody (1:2000 dilution, Vector, PI-1000) or peroxidase-labeled horse anti-mouse IgG antibody (1:4000 dilution, Vector, PI-2000) or horse anti-goat IgG antibody (1:2000 dilution, Vector, PI-9500). Immunoreactive species were visualized using the SuperSignal West Pico PLUS Chemiluminescent Substrate (ThermoFisher Scientific, 34580) and LAS 3000 cooled CCD camera (Fujifilm, Japan).

OXPHOS complex I enzyme activity assay

The mitochondrial fraction was used for the complex I enzyme activity assay (Abcam, ab109721). Samples were prepared by following the manufacture’s instruction and were diluted to the desired concentration in incubation solution. The sample (200 µl) was added to the pre-coated microplate (200 µl of incubation solution was added to measure the background signal), and the microplate was incubated for 3 h at 21 °C. After washing, 200 µl of assay solution (1× dilution buffer, 20× NADH, and 100× dye) was added to each well. The plate was read in kinetic mode, and the OD at 450 nm was measured at 21 °C. The result was expressed as mOD/min/100 µg protein.

Cyclophilin A measurement

The nuclear fraction was used for CYPA measurement (Abbexa, abx585050) following the manufacturer’s instructions. The sample and standard solution were added to a pre-coated plate and incubated for 90 min at 37 °C. After the incubation, the biotin-conjugated antibody was added. After incubation at 37 °C, 100 µl HRP solution was added and incubated for 30 min at 37 °C. After washing, 90 µl 3,3′,5,5′-Tetramethylbenzidine substrate was added and incubated for 20 min at 37 °C. After the final incubation, sulfuric acid stop solution was added and the absorbance at 450 nm was immediately measured. The result was expressed as pg/mg protein.

Caspase-3 activity assay

A total of 25 μl homogenate was mixed with 75 μl extraction buffer containing 50 mM Tris-HCl (pH 7.3), 100 mM NaCl, 5 mM EDTA, 1 mM EGTA, 1 mM PMSF, and 1% protease inhibitor cocktail on a microtiter plate. After incubation for 15 min at room temperature, 25 μM caspase-3-substrate (Ac-DEVD-AMC, Peptide Institute, 670613) in 100 μl assay buffer was added. Caspase-3 activity was measured using a Spectramax Gemini microplate fluorometer (excitation/emission wavelength 380/460 nm every 2 min for 2 h at 37 °C) and expressed as pmol AMC/mg protein per minute²⁸.

RNA extraction and sequencing

Cortical samples from P9 WT and AIF Tg mice were prepared for RNA sequencing. Total RNA from each sample was extracted using a RNeasy Mini kit (Qiagen, 74104), and the library preparation was done using an MGI Easy™ mRNA Library Prep Kit (BGI, Wuhan, China) following the manufacturer’s instructions. The sequencing library was used for cluster generation and sequencing on the BGISEQ-500 system (BGI)⁵⁷. The sequencing was repeated ten times, and the DESeq method was used to screen for between the two groups according to the criterion of p < 0.05. GO term classification was performed using the cluster Profiler R package⁵⁸.

RT-qPCR

Total RNA concentration and purity were determined using a Nanodrop spectrophotometer (Nanodrop Technologies, Wilmington, USA). One microgram of total RNA was reverse transcribed using the QuantiTect Reverse Transcription kit (Qiagen, 205311). RT-qPCR was performed using the LightCycler 480 instrument (Roche Diagnostics, Mannheim, Germany) and the SYBR green (ThermoFisher Scientific, 0253) technique according to the manufacturer’s instructions. The primers used in the qPCR reactions were designed by Beacon Designer software (PREMIER Biosoft) and were as follows: general Aif (sense: 5′-TATTTCCAGCCACCTTCTTTC-3′, anti-sense: 5′-TTCACCATGTTGCCTCTTAC-3′), Aif1 (sense: 5′-AGTCCTTATTGTGGGCTTATC-3′, anti-sense: 5′-GCAATGGCTCTTCTCTGTT-3′), Aif2 (sense: 5′-TTCTTAATTGTAGGAGCAACAGT-3′, anti-sense: 5′-CCCATCACTCTTTCATTGTAT CT-3′), and Sdha (the reference gene) (sense: 5′-TTGCCTTGCCAGGACTTA-3′, antisense: 5′-CACCTTGACTGTTGATGAGAAT-3′). The relative expression levels of mRNAs were calculated according to the formula of 2^−(ΔΔCT).

Statistical analysis

GraphPad Prism 6 Software (GraphPad Software, San Diego, CA, USA) was used for all analyses. Comparisons between groups were performed by Student’s t-test, and data with unequal variance were compared with the Mann–Whitney U-test. Two-way ANOVA followed by Sidak’s post hoc test was used for multiple comparisons of data from more than two groups. Results are presented as means ± standard deviation, and p < 0.05 was considered statistically significant.

References

Douglas-Escobar, M. & Weiss, M. D. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 169, 397–403 (2015).
Article PubMed Google Scholar
Black, R. E. et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375, 1969–1987 (2010).
Article PubMed Google Scholar
Laptook, A. R. et al. Effect of therapeutic hypothermia initiated after 6 h of age on death or disability among newborns with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA 318, 1550–1560 (2017).
Article PubMed PubMed Central Google Scholar
Giesinger, R. E., Bailey, L. J., Deshpande, P. & McNamara, P. J. Hypoxic-ischemic encephalopathy and therapeutic hypothermia: the hemodynamic perspective. J. Pediatr. 180, 22–30 e22 (2017).
Article PubMed Google Scholar
Zhu, C. et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124, e218–e226 (2009).
Article PubMed Google Scholar
Wu, Y. W. et al. High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial. Pediatrics. https://doi.org/10.1542/peds.2016-0191 (2016).
Article PubMed Google Scholar
Song, J. et al. Recombinant human erythropoietin improves neurological outcomes in very preterm infants. Ann. Neurol. 80, 24–34 (2016).
Article CAS PubMed PubMed Central Google Scholar
Wu, Y. et al. The potential role of ferroptosis in neonatal brain injury Front. Neurosci. https://doi.org/10.3389/fnins.2019.00115 (2019).
Northington, F. J., Chavez-Valdez, R. & Martin, L. J. Neuronal cell death in neonatal hypoxia-ischemia. Ann. Neurol. 69, 743–758 (2011).
Article CAS PubMed PubMed Central Google Scholar
Thornton, C. et al. Cell death in the developing brain after hypoxia-ischemia. Front. Cell Neurosci. 11, 248 (2017).
Article PubMed PubMed Central CAS Google Scholar
Xie, C. et al. Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury. Autophagy 12, 410–423 (2016).
Article CAS PubMed PubMed Central Google Scholar
Albertsson, A. M. et al. The immune response after hypoxia-ischemia in a mouse model of preterm brain injury. J. Neuroinflamm. 11, 153 (2014).
Article CAS Google Scholar
Zhu, C. et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ. 12, 162–176 (2005).
Article CAS PubMed Google Scholar
Sun, Y., Zhang, Y., Wang, X., Blomgren, K. & Zhu, C. Apoptosis-inducing factor downregulation increased neuronal progenitor, but not stem cell, survival in the neonatal hippocampus after cerebral hypoxia-ischemia. Mol. Neurodegener. 7, 17 (2012).
Article CAS PubMed PubMed Central Google Scholar
Hangen, E. et al. Interaction between AIF and CHCHD4 regulates respiratory chain biogenesis. Mol. Cell 58, 1001–1014 (2015).
Article CAS PubMed Google Scholar
Apostolova, N. et al. Loss of apoptosis-inducing factor leads to an increase in reactive oxygen species, and an impairment of respiration that can be reversed by antioxidants. Cell Death Differ. 13, 354–357 (2006).
Article CAS PubMed Google Scholar
Zhu, C. et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 14, 775–784 (2007).
Article CAS PubMed Google Scholar
Sun, Y. et al. Haploinsufficiency in the mitochondrial protein CHCHD4 reduces brain injury in a mouse model of neonatal hypoxia-ischemia. Cell Death Dis. 8, e2781 (2017).
Article CAS PubMed PubMed Central Google Scholar
Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549–554 (2001).
Article CAS PubMed Google Scholar
Cheung, E. C. et al. Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J. 25, 4061–4073 (2006).
Article CAS PubMed PubMed Central Google Scholar
Westrate, L. M., Drocco, J. A., Martin, K. R., Hlavacek, W. S. & MacKeigan, J. P. Mitochondrial morphological features are associated with fission and fusion events. PLos ONE. https://doi.org/10.1371/journal.pone.0095265 (2014).
Article PubMed PubMed Central Google Scholar
Chung, S. H., Calafiore, M., Plane, J. M., Pleasure, D. E. & Deng, W. Apoptosis inducing factor deficiency causes reduced mitofusion 1 expression and patterned Purkinje cell degeneration. Neurobiol. Dis. 41, 445–457 (2011).
Article CAS PubMed Google Scholar
Thornton, C. et al. Mitochondrial dynamics, mitophagy and biogenesis in neonatal hypoxic-ischaemic brain injury. FEBS Lett. 592, 812–830 (2018).
Article CAS PubMed Google Scholar
Grohm, J. et al. Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ. 19, 1446–1458 (2012).
Article CAS PubMed PubMed Central Google Scholar
Sanderson, T. H., Raghunayakula, S. & Kumar, R. Neuronal hypoxia disrupts mitochondrial fusion. Neuroscience 301, 71–78 (2015).
Article CAS PubMed Google Scholar
Kumar, R. et al. Mitochondrial dynamics following global cerebral ischemia. Mol. Cell Neurosci. 76, 68–75 (2016).
Article CAS PubMed PubMed Central Google Scholar
Sun, Y. et al. Dichloroacetate treatment improves mitochondrial metabolism and reduces brain injury in neonatal mice. Oncotarget 7, 31708–31722 (2016).
PubMed PubMed Central Google Scholar
Zhu, C. et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J. Neurochem. 86, 306–317 (2003).
Article CAS PubMed Google Scholar
Culmsee, C. et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J. Neurosci. 25, 10262–10272 (2005).
Article CAS PubMed PubMed Central Google Scholar
Vahsen, N. et al. AIF deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679–4689 (2004).
Article CAS PubMed PubMed Central Google Scholar
Hangen, E. et al. A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2. Cell Death Differ. 17, 1155–1166 (2010).
Article CAS PubMed Google Scholar
Rodriguez, J. et al. Lack of the brain-specific isoform of apoptosis-inducing factor aggravates cerebral damage in a model of neonatal hypoxia-ischemia. Cell Death Dis. 10, 3 (2018).
Article PubMed PubMed Central CAS Google Scholar
Zhu, C. et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J. Exp. Med. 204, 1741–1748 (2007).
Article CAS PubMed PubMed Central Google Scholar
Miramar, M. D. et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem. 276, 16391–16398 (2001).
Article CAS PubMed Google Scholar
Bano, D. & Prehn, J. H. M. Apoptosis-inducing factor (AIF) in physiology and disease: the tale of a repented natural born killer. EBioMedicine 30, 29–37 (2018).
Article PubMed PubMed Central Google Scholar
Joza, N. et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol. Cell Biol. 25, 10261–10272 (2005).
Article CAS PubMed PubMed Central Google Scholar
Hangen, E., Blomgren, K., Benit, P., Kroemer, G. & Modjtahedi, N. Life with or without AIF. Trends Biochem Sci. 35, 278–287 (2010).
Article CAS PubMed Google Scholar
Modjtahedi, N., Giordanetto, F. & Kroemer, G. A human mitochondriopathy caused by AIF mutation. Cell Death Differ. 17, 1525–1528 (2010).
Article CAS PubMed Google Scholar
Klein, J. A. et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419, 367–374 (2002).
Article CAS PubMed Google Scholar
Penninger, J. M. & Kroemer, G. Mitochondria, AIF and caspases—rivaling for cell death execution. Nat. Cell Biol. 5, 97–99 (2003).
Article CAS PubMed Google Scholar
Cande, C. et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23, 1514–1521 (2004).
Article CAS PubMed Google Scholar
Doti, N. et al. Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress. Cell Death Dis. 5, e993 (2014).
Article CAS PubMed PubMed Central Google Scholar
Pfisterer, U. & Khodosevich, K. Neuronal survival in the brain: neuron type-specific mechanisms. Cell Death Dis. 8, e2643 (2017).
Article CAS PubMed PubMed Central Google Scholar
Keller, D., Ero, C. & Markram, H. Cell densities in the mouse brain: a systematic review. Front Neuroanat. 12, 83 (2018).
Article CAS PubMed PubMed Central Google Scholar
Martin, L. J., Sieber, F. E. & Traystman, R. J. Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alterations in metabotropic glutamate receptor signaling pathways. J. Cereb. Blood Flow. Metab. 20, 153–167 (2000).
Article CAS PubMed Google Scholar
Wang, Y. et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science. https://doi.org/10.1126/science.aad6872 (2016).
Article PubMed PubMed Central CAS Google Scholar
Cao, G. et al. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J. Neurosci. 27, 9278–9293 (2007).
Article CAS PubMed PubMed Central Google Scholar
Wang, Y. et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 4, ra20 (2011).
PubMed PubMed Central Google Scholar
Zhang, J. et al. Augmentation of poly(ADP-ribose) polymerase-dependent neuronal cell death by acidosis. J. Cereb. Blood Flow. Metab. 37, 1982–1993 (2017).
Article CAS PubMed Google Scholar
Chaitanya, G. V., Steven, A. J. & Babu, P. P. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal 8, 31 (2010).
Article CAS PubMed PubMed Central Google Scholar
Blanquie, O. et al. Electrical activity controls area-specific expression of neuronal apoptosis in the mouse developing cerebral cortex. Elife. https://doi.org/10.7554/eLife.27696 (2017).
Weis, S. N. et al. Autophagy in the brain of neonates following hypoxia-ischemia shows sex- and region-specific effects. Neuroscience 256, 201–209 (2014).
Article CAS PubMed Google Scholar
Zhu, C. et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J. Neurochem. 96, 1016–1027 (2006).
Article CAS PubMed Google Scholar
Liesa, M. & Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 17, 491–506 (2013).
Article CAS PubMed PubMed Central Google Scholar
Li, Y. et al. Inhibition of Drp1 by Mdivi-1 attenuates cerebral ischemic injury via inhibition of the mitochondria-dependent apoptotic pathway after cardiac arrest. Neuroscience 311, 67–74 (2015).
Article CAS PubMed Google Scholar
Baburamani, A. A. et al. Mitochondrial optic atrophy (OPA) 1 processing is altered in response to neonatal hypoxic-ischemic brain injury. Int. J. Mol. Sci. 16, 22509–22526 (2015).
Article CAS PubMed PubMed Central Google Scholar
Xu, Y. et al. Cranial irradiation induces hypothalamic injury and late-onset metabolic disturbances in Juvenile female rats. Dev. Neurosci. 40, 120–133 (2018).
Article CAS PubMed Google Scholar
Yu, G. C., Wang, L. G., Han, Y. Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284–287 (2012).
Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

This work was supported by the National Nature Science Foundation of China (31761133015, U1704281, 81901335), the Swedish Research Council (2015-02845, 2017-01392), the Swedish Childhood Cancer Foundation (PR2016-072, PR2017-0043, NCp2015-0054, NCp2016-0019), the Swedish Cancer Foundation (CAN2017/509, CAN2017/586), Swedish Governmental grants to scientists working in health care (ALFGBG-717791, ALFGBG-716321, ALFSTHLM-20150541), the Swedish Brain Foundation (FO2018-0034), the Department of Science and Technology of Henan Province (171100310200), and the Chinese Scholarship Council to T.L. (201707040025), Y.W. (201807040027), and Y.X. (201507040082). G.K. is supported by the Ligue contre le Cancer (équipe labellisée); Agence National de la Recherche (ANR)—Projets blancs; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in China (GDW20171100085 and GDW20181100051), Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM). Open access funding provided by University of Gothenburg.

Author information

Authors and Affiliations

Henan Key Laboratory of Child Brain Injury, Institute of Neuroscience and Third Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China
Tao Li, Kenan Li, Shan Zhang, Yafeng Wang, Yiran Xu, Yanyan Sun, Xiaoyang Wang & Changlian Zhu
Center for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 40530, Sweden
Tao Li, Kenan Li, Shan Zhang, Yafeng Wang, Yiran Xu, Yanyan Sun, Yaodong Zhang, Cuicui Xie, Juan Rodriguez, Kai Zhou & Changlian Zhu
Department of Pediatrics, Children’s Hospital Affiliated of Zhengzhou University, Zhengzhou, 450018, China
Tao Li, Yafeng Wang & Yaodong Zhang
Institute of Molecular Biotechnology, Austrian Academy of Sciences, 1030, Vienna, Austria
Shane J. F. Cronin & Josef M. Penninger
Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
Cuicui Xie, Kai Zhou, Klas Blomgren & Changlian Zhu
Centre of Perinatal Medicine and Health, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 40530, Sweden
Henrik Hagberg, Carina Mallard, Xiaoyang Wang & Changlian Zhu
Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 40530, Sweden
Carina Mallard & Xiaoyang Wang
Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
Josef M. Penninger
Equipe labellisée par la Ligue contre le cancer, Université Paris Descartes, Université Sorbonne Paris Cité, Université Paris Diderot, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France
Guido Kroemer
Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France
Guido Kroemer
Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France
Guido Kroemer
Suzhou Institute for Systems Biology, Chinese Academy of Sciences, Suzhou, China
Guido Kroemer
Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Sweden
Guido Kroemer
Pediatric Hematology and Oncology, Karolinska University Hospital, Stockholm, Sweden
Klas Blomgren

Authors

Tao Li
View author publications
You can also search for this author in PubMed Google Scholar
Kenan Li
View author publications
You can also search for this author in PubMed Google Scholar
Shan Zhang
View author publications
You can also search for this author in PubMed Google Scholar
Yafeng Wang
View author publications
You can also search for this author in PubMed Google Scholar
Yiran Xu
View author publications
You can also search for this author in PubMed Google Scholar
Shane J. F. Cronin
View author publications
You can also search for this author in PubMed Google Scholar
Yanyan Sun
View author publications
You can also search for this author in PubMed Google Scholar
Yaodong Zhang
View author publications
You can also search for this author in PubMed Google Scholar
Cuicui Xie
View author publications
You can also search for this author in PubMed Google Scholar
Juan Rodriguez
View author publications
You can also search for this author in PubMed Google Scholar
Kai Zhou
View author publications
You can also search for this author in PubMed Google Scholar
Henrik Hagberg
View author publications
You can also search for this author in PubMed Google Scholar
Carina Mallard
View author publications
You can also search for this author in PubMed Google Scholar
Xiaoyang Wang
View author publications
You can also search for this author in PubMed Google Scholar
Josef M. Penninger
View author publications
You can also search for this author in PubMed Google Scholar
Guido Kroemer
View author publications
You can also search for this author in PubMed Google Scholar
Klas Blomgren
View author publications
You can also search for this author in PubMed Google Scholar
Changlian Zhu
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Changlian Zhu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by A. Verkhratsky

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Li, T., Li, K., Zhang, S. et al. Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice. Cell Death Dis 11, 77 (2020). https://doi.org/10.1038/s41419-020-2280-z

Download citation

Received: 21 October 2019
Revised: 14 January 2020
Accepted: 16 January 2020
Published: 30 January 2020
DOI: https://doi.org/10.1038/s41419-020-2280-z

This article is cited by

The lncRNA lnc_AABR07044470.1 promotes the mitochondrial-damaged inflammatory response to neuronal injury via miR-214-3p/PERM1 axis in acute ischemic stroke
- Meng Wang
- Hong Li
- Tao Yu
Molecular Biology Reports (2024)
Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation
- Cui Ma
- Xiaoying Wang
- Daling Zhu
Cell & Bioscience (2022)
Autophagy Inhibition Reduces Irradiation-Induced Subcortical White Matter Injury Not by Reducing Inflammation, but by Increasing Mitochondrial Fusion and Inhibiting Mitochondrial Fission
- Yafeng Wang
- Yiran Xu
- Changlian Zhu
Molecular Neurobiology (2022)
AIF Overexpression Aggravates Oxidative Stress in Neonatal Male Mice After Hypoxia–Ischemia Injury
- Tao Li
- Yanyan Sun
- Changlian Zhu
Molecular Neurobiology (2022)
The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status
- John Sieh Dumbuya
- Lu Chen
- Bin Wang
Journal of Neuroinflammation (2021)